FDA Clearance Tracker · P140017
MELODY TRANSCATHETER PULMONARY VALVE (TPV), ENSEMBLE TRANSCATHETER VALVE DELIVERY SYSTEM (DS)
Last checked: Nov 20, 2026Latest source record: Jan 27, 2015 (this decision)Source: openFDAMethods & limitations
Decided
Jan 27, 2015
Approved
Time to decision
159 days
Received Aug 21, 2014. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
The decision
- FDA number
- P140017
- Device name
- MELODY TRANSCATHETER PULMONARY VALVE (TPV), ENSEMBLE TRANSCATHETER VALVE DELIVERY SYSTEM (DS)
- Applicant
- Medtronic, Inc.
- Applicant location
- Mounds View, MN
- Received
- Aug 21, 2014
- Decided
- Jan 27, 2015
- Decision
- Approved
- Expedited review
- Yes, flagged as expedited in FDA's record.
- Supplements
- 33 in FDA's data for this PMA. See them on the FDA record
Device type
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL THE MELODY TRANSCATHETER PULMONARY VALVE (TPV) AND THE ENSEMBLE TRANSCATHETER VALVE DELIVERYSYSTEM. THIS DEVICE IS INDICATED FOR USE AS AN ADJUNCT TO SURGERY IN THE MANAGEMENT OF PEDIATRIC AND ADULT PATIENTS WITH THE FOLLOWING CLINICAL CONDITIONS:1) EXISTENCE OF A FULL (CIRCUMFERENTIAL) RIGHT VENTRICULAR OUTFLOW TRACT (RVOT) CONDUIT THAT WAS EQUAL TO OR GREATER THAN 16 MM IN DIAMETER WHEN ORIGINALLY IMPLANTED, AND 2) DYSFUNCTIONAL RVOT CONDUIT WITH A CLINICAL INDICATION FOR INTERVENTION, AND: A) REGURGITATION >= MODERATE REGURGITATION, AND/OR B) STENOSIS: MEAN RVOT GRADIENT >= MMHG.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code NPV (Pulmonary valve prosthesis percutaneously delivered).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
K262913 · Decided Sep 17, 2026 · 29 days after receipt
Device type: Stents, Drains And Dilators For The Biliary Ducts (FGE) · GI, Urology & Nephrology
K262735 · Decided Aug 28, 2026 · 28 days after receipt
Device type: Recorder, Event, Implantable Cardiac, (With Arrhythmia Detection) (MXD) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.